GlaxoSmithKline have announced new price reductions for HIV drugs for the world's poorest countries.

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.548, 2008-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GlaxoSmithKline (GSK) have asked government healthcare officials from several nations for opinions on which investigational drugs should be prioritised

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 558, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline extends preferential pricing

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline stops salmeterol study

Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline Medal of Merit 2008

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 4, 2008-12 ,pp. : 305-305

John Wiley & Sons Inc

Access to resources Recommend Favorite

GlaxoSmithKline Medal of Merit 2010

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 40, Iss. 4, 2010-12 ,pp. : 318-321

John Wiley & Sons Inc

Access to resources Recommend Favorite